PRICE T ROWE ASSOCIATES INC /MD/ - ALPINE IMMUNE SCIENCES INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q1 2024$122,101
+279.7%
3,080,220
+82.6%
0.02%
+275.0%
Q4 2023$32,161
+101.1%
1,687,278
+20.8%
0.00%
+100.0%
Q3 2023$15,991
+7038.8%
1,396,444
+6323.4%
0.00%
Q2 2023$224
+47.4%
21,740
+10.8%
0.00%
Q1 2023$152
+6.3%
19,625
+1.2%
0.00%
Q4 2022$143
-99.8%
19,401
+53.8%
0.00%
Q3 2022$91,00012,6150.00%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q2 2024
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,199,011$24,629,0003.99%
BVF INC/IL 675,759$7,569,0000.91%
Orbimed Advisors 3,298,516$36,943,0000.47%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 913,100$10,227,0000.40%
TIGER MANAGEMENT L.L.C. 162,728$1,823,0000.28%
Rock Springs Capital Management LP 150,000$1,680,0000.08%
Sowell Financial Services LLC 15,714$168,0000.04%
Spark Investment Management LLC 16,600$185,0000.01%
ALPINE WOODS CAPITAL INVESTORS, LLC 10,000$112,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 38,750$434,0000.01%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders